Literature DB >> 28004440

Patients' perception of chemotherapy side effects: Expectations, doctor-patient communication and impact on quality of life - An Italian survey.

Domenica Lorusso1, Emilio Bria2, Anna Costantini3, Massimo Di Maio4, Giovanni Rosti5, Annamaria Mancuso6.   

Abstract

Chemotherapy side effects (CSE) have a strong impact on patients' quality of life (QOL). To assess patient perceptions of CSE, their impact on QOL and doctor-patient communication regarding these aspects, a survey was conducted among Italian cancer patients. Patients at least 18 years of age, who received chemotherapy, were administered a dedicated questionnaire to assess their point of view on five domains: expectations about CSE and impact on QOL; doctor-patient communication about CSE; treatments to reduce the impact of CSE; sexual life; family relationships/activities and employment. A total of 761 patients participated. CSE had a considerable impact on patient QOL. Nausea/vomiting was the most feared adverse effect before initiating chemotherapy and the one most commonly experienced during treatment. Patients generally reported good doctor-patient communication regarding information about CSE. In almost all cases, the oncologists prescribed an antiemetic treatment, but the incidence of nausea/vomiting was high. Cancer and CSE severely affected sexual life, daily activities and employment. CSE had a strong negative impact on QOL. Good doctor-patient communication is essential. Improving antiemetic strategies may improve QOL. Doctors' ability to inform patients about delicate issues, such as the impact of CSE on sexual life, needs to be improved.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  chemotherapy side effects; nausea and vomiting; quality of life of life; supportive care

Mesh:

Substances:

Year:  2016        PMID: 28004440     DOI: 10.1111/ecc.12618

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  14 in total

1.  Chemotherapy-induced nausea and vomiting control in pediatric patients receiving ifosfamide plus etoposide: a prospective, observational study.

Authors:  Priya Patel; Sara R Lavoratore; Jacqueline Flank; Meaghan Kemp; Ashlee Vennettilli; Helen Vol; Tracey Taylor; Elyse Zelunka; Anne Marie Maloney; Paul C Nathan; L Lee Dupuis
Journal:  Support Care Cancer       Date:  2019-06-08       Impact factor: 3.603

Review 2.  Bioengineering Solutions for Manufacturing Challenges in CAR T Cells.

Authors:  Nicole J Piscopo; Katherine P Mueller; Amritava Das; Peiman Hematti; William L Murphy; Sean P Palecek; Christian M Capitini; Krishanu Saha
Journal:  Biotechnol J       Date:  2017-09-18       Impact factor: 4.677

Review 3.  Stimuli-responsive polymeric micelles for drug delivery and cancer therapy.

Authors:  Qing Zhou; Li Zhang; TieHong Yang; Hong Wu
Journal:  Int J Nanomedicine       Date:  2018-05-18

4.  Safety and efficacy of netupitant/palonosetron and dexamethasone in classical Hodgkin's lymphoma patients with inadequate chemotherapy-induced nausea and vomiting prophylaxis with palonosetron and dexamethasone: a single-center real-life experience.

Authors:  Vittorio R Zilioli; Cristina Muzi; Periana Minga; Paolo Codega; Lara Crucitti; Erika Meli; Anna Esposito; Claudia Panico; Chiara Rusconi; Roberto Cairoli
Journal:  Int J Hematol Oncol       Date:  2020-02-28

5.  Cancer Patients' Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life.

Authors:  Robert S Epstein; Upal K Basu Roy; Matti Aapro; Tehseen Salimi; Donald Moran; JoAnn Krenitsky; Megan L Leone-Perkins; Cynthia Girman; Courtney Schlusser; Jeffrey Crawford
Journal:  Patient Prefer Adherence       Date:  2021-02-25       Impact factor: 2.711

Review 6.  Skin cancer biology and barriers to treatment: Recent applications of polymeric micro/nanostructures.

Authors:  Nazeer Hussain Khan; Maria Mir; Lei Qian; Mahnoor Baloch; Muhammad Farhan Ali Khan; Asim-Ur- Rehman; Ebenezeri Erasto Ngowi; Dong-Dong Wu; Xin-Ying Ji
Journal:  J Adv Res       Date:  2021-06-16       Impact factor: 10.479

7.  Girinimbine Inhibits the Proliferation of Human Ovarian Cancer Cells In Vitro via the Phosphatidylinositol-3-Kinase (PI3K)/Akt and the Mammalian Target of Rapamycin (mTOR) and Wnt/β-Catenin Signaling Pathways.

Authors:  Qiu Xin; An Muer
Journal:  Med Sci Monit       Date:  2018-08-07

8.  Cost-utility and budget impact analyses of the use of NEPA for chemotherapy-induced nausea and vomiting prophylaxis in Italy.

Authors:  Umberto Restelli; Gabriella Saibene; Patrizia Nardulli; Roberta Di Turi; Erminio Bonizzoni; Francesca Scolari; Tania Perrone; Davide Croce; Luigi Celio
Journal:  BMJ Open       Date:  2017-08-01       Impact factor: 2.692

9.  Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia.

Authors:  Lindsay J Collin; Ming Yan; Renjian Jiang; Kevin C Ward; Brittany Crawford; Mylin A Torres; Keerthi Gogineni; Preeti D Subhedar; Samantha Puvanesarajah; Mia M Gaudet; Lauren E McCullough
Journal:  NPJ Breast Cancer       Date:  2019-09-26

10.  Investigation of the differences between the medical personnel's and general population's view on the doctor-patient relationship in China by a cross-sectional survey.

Authors:  Tianqing Sang; Hongli Zhou; Muhan Li; Wenting Li; Haibo Shi; Haibin Chen; Hongguang Zhou
Journal:  Global Health       Date:  2020-10-15       Impact factor: 4.185

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.